Your browser doesn't support javascript.
loading
Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
Narr, Kerstin; Ertuna, Yusuf I; Fallet, Benedict; Cornille, Karen; Dimitrova, Mirela; Marx, Anna-Friederike; Martin, Katrin; Abreu Mota, Tiago; Künzli, Marco; Schreiner, David; Brunner, Tobias M; Kreutzfeldt, Mario; Wagner, Ingrid; Geier, Florian; Bestmann, Lukas; Löhning, Max; Merkler, Doron; King, Carolyn G; Pinschewer, Daniel D.
Afiliación
  • Narr K; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Ertuna YI; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Fallet B; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Cornille K; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Dimitrova M; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Marx AF; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Martin K; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Abreu Mota T; Division of Experimental Virology, Department of Biomedicine, University of Basel, 4003 Basel, Switzerland.
  • Künzli M; Immune Cell Biology Laboratory, Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland.
  • Schreiner D; Immune Cell Biology Laboratory, Department of Biomedicine, University Hospital Basel, 4031 Basel, Switzerland.
  • Brunner TM; Experimental Immunology and Osteoarthritis Research, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Kreutzfeldt M; Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center, Leibniz Institute, 10117 Berlin, Germany.
  • Wagner I; Division of Clinical Pathology, Geneva University Hospital, 1211 Geneva, Switzerland.
  • Geier F; Department of Pathology and Immunology, Geneva Faculty of Medicine, Geneva University Hospital, 1211 Geneva, Switzerland.
  • Bestmann L; Department of Pathology and Immunology, Geneva Faculty of Medicine, Geneva University Hospital, 1211 Geneva, Switzerland.
  • Löhning M; Department of Biomedicine, Bioinformatics Core Facility, University Hospital Basel, 4031 Basel, Switzerland.
  • Merkler D; Medisupport, Medizinische Laboratorien Dr. Toggweiler, 8304 Wallisellen, Switzerland.
  • King CG; Experimental Immunology and Osteoarthritis Research, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Pinschewer DD; Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center, Leibniz Institute, 10117 Berlin, Germany.
Proc Natl Acad Sci U S A ; 118(46)2021 11 16.
Article en En | MEDLINE | ID: mdl-34772811
ABSTRACT
Chronic viral infections subvert protective B cell immunity. An early type I interferon (IFN-I)-driven bias to short-lived plasmablast differentiation leads to clonal deletion, so-called "decimation," of antiviral memory B cells. Therefore, prophylactic countermeasures against decimation remain an unmet need. We show that vaccination-induced CD4 T cells prevented the decimation of naïve and memory B cells in chronically lymphocytic choriomeningitis virus (LCMV)-infected mice. Although these B cell responses were largely T independent when IFN-I was blocked, preexisting T help assured their sustainability under conditions of IFN-I-driven inflammation by instructing a germinal center B cell transcriptional program. Prevention of decimation depended on T cell-intrinsic Bcl6 and Tfh progeny formation. Antigen presentation by B cells, interactions with antigen-specific T helper cells, and costimulation by CD40 and ICOS were also required. Importantly, B cell-mediated virus control averted Th1-driven immunopathology in LCMV-challenged animals with preexisting CD4 T cell immunity. Our findings show that vaccination-induced Tfh cells represent a cornerstone of effective B cell immunity to chronic virus challenge, pointing the way toward more effective B cell-based vaccination against persistent viral diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virosis / Vacunas / Linfocitos B / Linfocitos T CD4-Positivos / Infección Persistente Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virosis / Vacunas / Linfocitos B / Linfocitos T CD4-Positivos / Infección Persistente Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2021 Tipo del documento: Article País de afiliación: Suiza